|
LADIES LEUKEMIA LEAGUE
RESEARCH GRANT RECIPIENTS
1971-2017
| 1971-72 |
Charity Hospital |
$4,000.00 |
| 1972-73 |
Leukemia Society
Leukemia Trust Fund |
$2,500.00 |
| 1974 |
Kathy McDaniel |
$350.00 |
|
Leukemia Society |
$3,233.66 |
|
Children's Hospital |
$590.00 |
|
Dr. William Barrios |
$2,500.00 |
|
Leukemia Society |
$1,244.52 |
|
Edgar Hull, M.D. |
$1,315.00 |
|
M.D. Anderson |
$1,500.00 |
| 1975 |
Jensie H. Tou |
$1,900.00 |
|
Dr. Robert Gallo |
$550.00 |
| 1976-77 |
Louisiana Cancer Center |
$500.00 |
| 1979 |
LSU Dept. of Pediatrics |
$1,100.00 |
|
Leukemia Society |
$1,972.00 |
|
Leukemia Society |
$3,000.00 |
| 1979-80 |
Leukemia Society |
$3,000.00 |
| 1980-81 |
Leukemia Society |
$4,980.00 |
| 1981-82 |
Leukemia Society |
$9,185.31 |
| 1981 |
Tulane |
$21,000.00 |
|
LSU |
$6,000.00 |
| 1981-83 |
Children's Hospital |
$13,000.00 |
| 1983 |
Dr. Schor |
$4,200.00 |
| 1983 |
Dr. S.H. Leech |
$4,490.00 |
| 1985-1989 |
Dr. Stephen P. Squntie
LSU |
$17,500.00 |
|
Project: Human Recombinant Tumor Necrosis Factor Induction of Differentiation of Acute Lymphoblastic Leukemia Cells.
|
|
Dr. Emile Freireich
M.D. Anderson |
$50,616.00 |
|
Project: Autologous Natural Killer (NK) Cell Therapy of Leukemia
|
|
Dr. Deborah A. Abertnathy
Tulane |
$19,203.00 |
|
Project: In Vitro Effects of Retinoids and Recombinant Growth Factors on Normal and Myelodysplastic (Pre-leukemia) Hemopoietic Precursors and its Clinical Significance.
|
| 1989-90 |
Dr. Barbara Beckman
Tulane |
$10,000.00 |
|
Project: Nuclear events in Leukemia Cells.
|
| 1990-92 |
Dr. Hung Yuen Yeh
LSU |
$21,383.00 |
|
Project: The Usefulness of Soluble Interleukin-2 Receptor, Soluble CD8 Antigen and Protein Kinase C Activity in Childhood Acute Lymphoblastic Leukemia. |
|
Comment: Seven patients with acute lymphoblastic leukemia were entered on the study and have been followed up for a minimum of 15 months and a maximum of 24 months.
A manuscript has been written on the first five patients and submitted for publication.
|
|
Dr. R.P. Warrier
LSU |
$30,000.00 |
|
Project: Research of childhood leukemia.
|
|
Dr. Albert Desserath
M.D. Anderson |
$50,000.00 |
|
Project: Moleculr Approaches to the Therapy of Leukemia |
|
Comment: Published in The Journal of Biological Chemistry.
|
|
Dr. James R. Jeter
Tulane |
$21,200.00 |
|
Project: Molecular Events in the Regulation of Hematopoiesis
|
|
Dr. Cindy Leissenger
Tulane |
$21,660.00
|
| 1993-94 |
Dr. Marion Feistadt
LSU |
$20,764.00 |
|
Project: A Simple and Novel Protocol to Identify the HTLV-1 Cell Surface Receptor. |
|
Comment: Received a grant from the Cancer Association of Greater New Orleans to continue project.
|
| 1994-95 |
Dr. Wayne Vedecksi
LSU |
$23,000.00 |
|
Project: "Characterization of p90, a new marker for acute Promyelocylic Leukemia". |
|
Comment: "We have succeeded in implementing the RT-PCR assay for acute promyelocytic leukemia (APL) in our lab. We have followed an APL patient for two years, and the assay results agree with the clinical course of the disease".
|
|
Dr. Laura Levy
Tulane |
$22,500.00 |
|
Project: Molecular Determinants of Lymphoid Malignancy |
|
Comment: This project appeared in four publications, including the Journal of Virology and the International Journal of Cancer.
|
|
Dr. David J. Carr
LSU |
$20,959.00 |
|
Project: Aberrant Regulation of Cytokines in HIV-1 TAT72 Transgenic Mice. |
|
Comment: Published in The Journal of Immunology.
|
|
Dr. Michael Andreeff
M.D. Anderson |
$20,800.00 |
|
Project: Leukemia |
|
Comment: The result of this project was presented at the Annual Meeting of the American Society of Hematology. This project was published in the Blood Journal
.
|
| 1995-96 |
Dr. Ronald Luftig
LSU |
$23,200.00 |
|
Project: Actin Cytoskeleton in Leukemia Virus Morphogenesis |
|
Comment: This abstract was presented at the Annual Meeting of the American Society for Virology.
|
|
Dr. Rene Gardner |
$29,000.00 |
|
Project: Long-Term Hemopoietic Injury Induced by Chemotherapy
|
|
FILE MISSING |
$31,700.00
|
|
|
| 1996-97 |
Dr. Madeleine Duvic
Univ. of Texas-Houston |
$37,500.00 |
|
Project: Pathenogeneis of Sezary Syndrome |
|
Comment: This project was published in The Journal Blood.
|
|
Dr. Jiandong Chen
LSU |
$21,995.00 |
|
Project: The Proleolytic Cleavage of the md m 2 Oncogene Product Dureng p52 mediated Apoptosis.
|
|
Dr. Maria Velez-LSU |
$24,000.00 |
|
Project: Efficacy of Corticosteroid Treatment in Primary and Relapse Leukemia Patients: Role of Glucocorticoid Receptor Gene. |
|
Comment: Collaborating with the University of Mississippi and Children's Hospital in Los Angeles, Michigan and Tampa.
|
|
Dr. Barbara Beckman
Tulane |
$14,800.00 |
|
Project: The Molecular Mechanism of Multidrug Resistance in Leukemia. |
|
Comment: This project appeared in two journals.
|
| 1997-98 |
Dr. Eric S. Johnson
Tulane |
$40,540.00 |
|
Project: Detection of Avian Leukosis/Sarcoma Viruses (ALSV) in the Genome of Human Leukemia and Lymphoma Tumor Cells. |
|
Comment: As a result of the preliminary findings he recently was awarded a two-year grant from the NIH.
|
|
Jorge Cortes, M.D.
M.D. Anderson |
$42,800.00 |
|
Project: Immune Recognition OF p210 Cra/Abl in Patients with Chronic Myelogenous Leukemia. |
|
Comment: Significant progress in the identification of specific immune recognition of p210 BCR/ABL, both by cellular and humoral mechanisms, and correlation with response to Interferon treatment.
|
|
Dr. Paul Schwarzenberger
LSU |
$19,880.00 |
|
Project: Development of a gene therapy based bone marrow purging system for leukemia patients.
|
| 1998-99 |
David Good, M.D.
LSU |
$30,000.00 |
|
Project: Selective Targeting of Hematopoietic Stem Cells via the c-kit Receptor.
|
|
Patricia D. Castro, Ph.D. and Lalitha Nagarajan, Ph.D
M.D. Anderson |
$33,000.00 |
|
Project: Deletions of chromosome 5Q 13.3 and 17p loci cooperate in myeloid neopla. |
|
Comment: Received honorable mention in the Bristol-Myers Squibb Award in Clinical/Translational Science. This project was published in the March 1999 issue of BLOOD JOURNAL. Applied for an $800,000 federal grant on this project. The review is quite favorable.
|
|
Chris Theodossiou, M.D.
LSU |
$45,540.00 |
|
Project: Investigation of IL 17 in Patients with Bone Marrow Failure.
|
|
Laura Levy, Ph.D. |
$19,500.00 |
|
Project: Role of the Immune Environment in the Development of Lymphoma. |
|
Comment: The results were published in a manuscript by Beaty, R.M., K. Rulli, L. Bost, J. Pantginis, J. Lenz and L.S. Levy, L99 high levels of Il-4 and 11-10mRNA and low levels of Il-2 and IFN-Yymrna in MuL V-induced lymphomas. Published in GENE (An International Journal on Genes, Genomes and Evolution): Identification and analysis of a third mouse Polycomb gene MPC3.
Received additional funding from American Cancer Society and Development Funds from the Tulane Cancer Center.
|
| 1999-2000 |
Marina Konopleva, M.D. Ph.D.
M.D. Anderson |
$58,724.00 |
|
Project: Therapy of AML. |
|
Comment: Submitted to NCI. Preliminary results obtained have assisted in being awarded the W.M. Keck Foundation Grant at the University of Texas, M.D. Anderson Center "Anti-apoptotic Protein Survivin as a New Target in AML Therapy".
The research conducted under this grant award also assisted in renewing an NCI grant award.
|
|
Charles S. Hemenway, M.D., Ph.D.
Tulane |
$10,000.00 |
|
Project: Analysis of a third mouse Polycomb gene, MPc3 |
|
Comment: Paper published in GENE (An International Journal on Genes, Genomes and Evolution) on protocol Identification and Analysis of a Third Mouse Polycomb gene, MPc3.
|
|
Kevin D. Brown, Ph.D.
LSU |
$34,550.00 |
|
Project: ATM KINANSE DOMAI |
|
Comment: This project was submitted to the journal Biotechniques. A grant request was made to NIH for this project. This project established a new avenue of investigation (colon cancer gene). A manuscript is being published at this time.
|
| 2000-2001 |
Richard H. Scheurmann, Ph.D
UT Southwest Medical Center, Dallas |
$49,500.00 |
|
Project: Targeting Peptides for T-Cell Acute Lymphoblastic Leukemia Therapy. |
|
Comment: Seeking additional funding to continue the project.
|
|
Guillermo Garcia-Manero, M.D
M.D. Anderson |
$40,000.00 |
|
Project: "Post-remission immunotherapy of acute myelogenous leukemia with an autologous dinitrophenyl (DNP)-modified leukemia cell vaccine". |
|
Comment: This study has allowed us to better understand the theraputic needs of patients with advance AML and potentially develop similar programs for patients in first remission or after allogeneic bone marrow transplantation.
|
|
Reeves Huie, Ph.D.
M.D. Anderson |
$35,000 |
|
Project: Evaluation of Plasma 5-Oxoprolime as a Convenient Marker of Apoptosis in Leukemia
|
|
Comment: Grant funds were returned. Dr. Huie left M.D. Anderson before project was started.
|
| 2001-2002 |
Francesco Onida, M.D.
M.D. Anderson |
$30,000.00 |
|
Project: Development of New Combination Therapies for Philadelphia Chromosome Positive Leukemia |
|
Comment: Submitted project to the Cancer publication.
Result of this study was presented at the Annual Meeting of the American Society of Hematology.
|
|
Renee V. Gardner, M.D.
LSU |
$29,742.00 |
|
Project: A Study of Rasayanas as a Cardioprotectant Agent Through Antioxidation
|
|
Laura Levy, Ph.D.
Tulane |
$34,989.00 |
|
Project: Clinical and Laboratory Predictors of Lymphoma in the Nonhuman Primate Model.
|
|
Angus McLeod Sinclair, Ph.D.
UT, Dallas |
$35,000.00 |
|
Project: Role of Transcriptional Repressor CDP in myeloid Leukemia.
|
|
Li Li, M.D. Ph.D.
Ochsner |
$30,000.00 |
|
Project: Stromal Cell Molecules Required for Malignant-B Cell Tumor Generation in Vivo.
|
| 2002-2003 |
Dr. Bing Z. Carter
M.D. Anderson |
$35,000.00 |
|
Project: "Target Antiapoptotic Survivin in Acute Myelogenous Leukemia."
|
|
Laura Levy, Ph.D.
Tulane |
$35,000.00 |
|
Project: Growth Regulations of SAIDS-Associated Lymphomas
|
|
Dr. Srdan Verstovsek
M.D. Anderson |
$30,000.00 |
|
Project: "Targeted Anti-Angiogenesis Therapy of Myeloid Bone Marrow Diseases."
|
|
Dr. Mansour Mohamadzadeh
Tulane |
$30,000.00 |
|
Project: Development of a Novel Il-15 Based Vaccine to Treat Cutaneous T Cell Lymphoma. |
|
Dr. Yan Cui
LSU |
$30,000.00 |
|
Project: Empower the Immune System to Combat Leukemia: Combination Immunotherapy of Targeting Tumor Antigen to Dendritic Cella and GM-CSF Enchanced Antigen Presentation.
|
| 2003-2004 |
Seth J. Corey, M.D. MPH
M.D. Anderson |
$30,000.00 |
|
Project: "siRNA Tareting of Lyn Tyrosine Kinase in Acute Leukemia"
|
|
Bulent Ozspolat, M.D., Ph.D.
M.D. Anderson |
$32,500.00 |
|
Project:"Identification of Novel Molecular Targets in All-Transretinoic Acid (ATRA) Induced Differentiation and Resistance in Acute Promyeloctic Leukemia Through Expression Proteomics Analysis"
|
|
Frank C. Marini, Ph.D.
M.D. Anderson |
$30,000.00 |
|
Project: "Mesenchymal Stem Cells (Stromal Cells) Expressing Interferon as a Targeted Antileukemia Therapy"
|
|
Charles S. Hemenway, M.D., Ph.D.
Tulane University School of Medicine |
$34,187.00 |
|
Project: "Development of a Model of Infant Leukemia for Targeted Therapeutics"
|
| 2004-2005 |
Bing Z. Carter, Ph.D
M.D. Anderson |
$35,000.00 |
|
Project: "The X-chromosome-linked Inhibitor of Apoptosis as a Therapeutic Target for the Treatment of Acute Myeloid Leukemia" |
|
Laura S. Levy, Ph.D.
Tulane University School of Medicine |
$35,000.00 |
|
Project: "Novel Retroviruses as Tools for the Discovery of Oncogenes Associated with Lymphoma" |
|
Bo Xu, M.D., Ph.D.
LSU Health Sciences Center |
$35,000 |
|
Project:"Interfering with DNA Damage Signals: Chemo-sensitizing Leukemia Using Small Peptides"
|
| 2005-2006 |
Erik K. Flemington, Ph.D.
Tulane Health Sciences Center, Department of Pathology, SL79 |
$25,000.00 |
|
Project:"Identification of EBV regulated cellular genes that contribute to EBV associated lymphomas" |
|
Soung-Chul Cha, Ph.D., M.D
University of Texas, MD Anderson Cancer Center |
$25,000.00 |
|
Project: "Discovering novel lymphoma antigens as targets for immunotherapy" |
|
Xiao Ni, M.D. Ph.D.
University of Texas, MD Anderson Cancer Center |
$25,000 |
|
Project:"Induction of Polyclonal T-Cell Responses against Cutaneous T-Cell Lymphomas by Autologous Dendritic Cells Transfected with Amplified Tumor RNA"
|
|
Mary Ann Weiser, M.D. Ph.D.
University of Texas, MD Anderson Cancer Center |
$25,000.00 |
|
Project: "Effects of hyperglycemia and AKT Activation on Chemo Resistance of Blasts from Patients with Acute Lymphocytc Leukemia" |
|
Rui-Yu Wang, M.D., Ph.D.
University of Texas, MD Anderson Cancer Center |
$25,000 |
|
Project:"The Role of Apoptotic Inducing Factor (AIF) IN Acute Myeloid Leukemia"
|
| 2007-2008 |
Terzah M. Horton, M.D. Ph.D.
Texas Children's Cancer Center,
Baylor College of Medicine |
$30,000.00 |
|
Project:Targeting Pediatric Leukemia Stem Cells to Enhance Treatment Response rates |
|
Marilyn M. Li, M.D.
Tulane University Health Science Center,
Hayward Genetics Center |
$30,000.00 |
|
Project: MLL partial tandem duplications in prenatal tissues and cord blood: Benign Micro-mosaicism or Laten Predisposition |
|
Xin Lin, Ph.D.
University of Texas, MD Anderson Cancer Center, Associate Professor, Department of Molecular and Cellular Oncology |
$30,000.00 |
|
Project:CARMA 1 (a scaffold molecule) - associated NF-AF activation in diffuse large B cell lymphoma
|
| 2008-2009 |
Shuo Dong, M.D., Ph.D
Baylor College of Medicine |
$33,500.00 |
|
Project: Histone Demethylase RADMI in the Pathogenisis of Acute Promyelocytic Leukemia
|
|
LiLi, M.D., Ph.D
Cellular Immunology Dept, Ochsner Clinic Foundation |
$35,000.00 |
|
Project: Identification o B-Cell Lymphoma Stem Cells and their Microenvironmental Factors |
|
Paulo C. Rodriguez, Ph.D.
LSU Health Science Center |
$35,000.00 |
|
Project:Project: L-Arginine Availability Regulates Proliferation of Malignant T-Cells
|
|
Amos Gaikwad, Ph.D
Baylor College of Medicine |
$35,000.00 |
|
Project: Study of novel therapeutic Agents to Target the Leukemic Stem Cells |
|
Ajoy Kumar Samanta, Ph.D.
M.D. Anderson Cancer Center |
$35,000.00 |
|
Project: Therapeutic Evaluation of New Small Molecule WP1193 Targeting Bcr-Abl Driven JAK-STAT Pathway for Treatment of Imatinib Resistant Chronic Myelogenous Leukemia
|
| 2009-2010 |
M. James You, M.D., Ph.D.
Assistant Professor, The University of Texas M.D. Anderson Cancer Center |
$35,000.00 |
|
Project: Generation and Characterization of T-all with Deficiency in Pten and Ink4A/ARF Tumor Suppressors. |
|
Felipe Samaniego, M.D.
The University of Texas M.D. Anderson Cancer Center |
$35,000.00 |
|
Project: Targeting of FAS Inhibitor CD 74 in Human Chronic Lymphocytic Leukemia (CLL) with anti-CD74 antibody. |
|
Xiaoping Sun, M.D., Ph.D.
The University of Texas M.D. Anderson Cancer Center |
$35,000.00 |
|
Project:Project: Role of SOX4 in the interaction between Leukemic Cells and Bone Marrow Niches
|
|
Laura S. Levy, Ph.D.
Tulane University School of Medicine |
$35,000.00 |
|
Project: Protien Kinase C-beta (PKCB) as a Potential Therapeutic Target in Lymphoma. |
|
Deepa Sampath, Ph.D.
The University of Texas M.D. Anderson Cancer Center |
$35,000.00 |
|
Project: Targeting Epigenetically-silenced MicroRNA Pathways for the therapy of Chronic Lymphocytic Leukemia. |
|
Lynne V. Abruzzo, M.D., Ph.D.
The University of Texas M.D. Anderson Cancer Center |
$35,000.00 |
|
Project: Genomic Evolution in Patients with Chronic Lymphocytic Leukemia Treated With FCR Chemoimmunotherapy. |
| 2010-2011 |
Laurance J.N. Cooper, M.D., Ph.D.
The University of Texas M.D. Anderson Cancer Center |
$35,000.00 |
|
Project: Immune-based Therapy for Malignant T Cells. |
|
Erik Flemington, Ph.D.
Tulane Health Sciences Center |
$35,000.00 |
|
Project: Targetome Analysis of Epstein Barr (EBV) encoded mcroRNAs |
|
Shuo Dong, M.D.
Baylor College of Medicine |
$35,000.00 |
|
Project: Targeting STAT3 Pathway in the Suppression of MLL Fusion Protein Mediated Transformation
|
|
Michele Redell, M.D., Ph.D.
Baylor College of Medicine |
$35,000.00 |
|
Project: Understanding and Overcoming Chemotherapy Resistance in Pediatric Acute Myeloid Leukemia |
| 2011-2012 |
Tara L. Lin, M.D.,
LSU Health Sciences Center
$35,000.00
Project: Chemotherapy resistance in Acute Lymphocytic Leukemia: the role of Hedgehog pathway signaling
Yu-Ping Wang
Tulane University
$35,000.00
Project: Bioinformatics technique for accurate subtype classification of myelodysplastic
syndrome (MDS).
Xiao-Tong Song, Ph.D.
Baylor College of Medicine
$35,000.00
Project: Tumor Stroma-Targeted Dendritic Cell Vaccine for B cell Lymphoma
M. James You, MD, Ph.D.
MD Anderson Cancer Center
$35,000.00
Project: Role of ECRGA in Acute Myeloid Leukemia
Bryant G. Damay, Ph.D.
MD Anderson Cancer Center
$35,000.00
Project: Evaluation of TAK1 as a New Tumor Suppressor Gene for Myeloid Leukemia
|
| 2012-2013 |
Shuo Dong, M.D., Ph.D.
Baylor College of Medicine
$35,000.00
Project: Histone demethylase function as tumor suppressor in MLL-mediated
leukemogenesis
Karen Rabin, M.D., Ph.D.
Baylor College of Medicine
$35,000.00
Project: Discovery of Novel Therapeutic Targets in Acute Lymphoblastic
Leukemia by shRNA
Laura S. Levy, Ph.D.
Tulane University School of Medicine
$35,000.00
Project: Beta-Catenin Accumulation as an Apoptotic Signal in B-cell
Acute Lymphoblastic Leukemia
Lily Jun-shen Huang, Ph.D.
UT Southwestern Medical Center
$35,000.00
Project: Identify and characterize leukemic stem cells in
myeloproliferative neoplasms
Alfonso Quintas-Cardama, M.D.
The University of Texas MD Anderson Cancer Center
$35,000.00
Project: Therapy with novel CBP-beta-Catenin inhibitor PRI-724 for the
Cure of Patients with Chronic Myeloid Leukemia Carrying Minimal residual
Disease while on Therapy with Tyrosine Kinase Inhibitors |
|
2013-2014
|
Hua Lu, MD, PhD $35,000
Tulane University School of Medicine
Project: Preclinical Evaluation of a Novel Small Molecule Inauhzin-37
as Potential
Leukemia/lymphoma Therapy
Joseph A. Lasky, MD $25,000
Tulane University School of Medicine
Project: The use of Arsenic Trioxide and Ganciclovir in the Induction of
Apoptosis In Epstein-Barr Driven Primary Lymphoma Cell Lines and in an
in vivo Model of Post-transplant Lymphoproliferative Disease
LiLi, MD, PhD $25,000
Tom Benson Cancer Center
Project: Identification of Prognostic Markers in Follicular Lymphoma
Zhihong Zeng, MD
MD Anderson Cancer Center
Project: Investigating the molecular of microenvironment-mediated drug
resistance in leukemia stem cells by CyTOF mass cytometry
|
| 2014-2015 |
Zhiqiang Qin, MD, PhD - $30,000
LSU Health Sciences Center New Orleans
PROJECT: The role of HGF/c-MET Pathway in AIDS-related Lymphoma
Stephen Gottschalk, MD - $35,000
Baylor College of Medicine
PROJECT: T-cell Therapy for Acute Myelogenous Leukemia
Sean M. Post, PhD - $35,000
MD Anderson Cancer Center
PROJECT: hnPNP K expression and leukemia: Walking the tightropeJinsheng
Weng, PhD - $35,000
The University of Texas
Project: Targeting CLL and through tumor antigen specific T cells
|
| 2015-2016 |
Hua Lu, MD, PhD $30,000
Tulane University School of Medicine
PROJECT: Targeting GRP78 by PNIN as Potential and Novel
Leukemia/lymphoma Therapy
Thomas Keen, PhD $35,000
Baylor College of Medicine
PROJECT: Improved engraftment of umbilical cord blood stem cells using a
bone marrow targeting peptide.
Alessandra Ferrajoli, MD $30,000
MD Anderson Cancer Center
Project: Clinical and Genomic Studies of Other Cancers in Patients with
Chronic Lymphocytic Leukemia.
Weiguo Zhang, MD, PhD $30,000
MD Anderson Cancer Center
Project: Mechanism-based combinatorial Strategy for targeting
leukemic-initiating cells in relapsed acute myeloid leukemia with FLT3/ITD
mutations |
| 2016-2017 |
Nakhle Saba, MD Tulane University School of
Medicine - $27,000
Project: Investigating the Role of the Novel
RELA E39Q Mutation in Mantle Cell Lymphoma
Zachary Prsell, PhD Tulane University School of
Medicine - $27,000
Project: Characterization of Novel Biomarkers
of therapy-related AML/MDS
Courtney DiNardo, MDE MD Anderson Cancer Center -
$27,000
Project: Evaluation of D-2HG levels in AML
patients with 1DH1 and/or IDH2 mutations receiving therapy
Janos Roszik and Naval Daver MD Anderson Cancer
Center - $27,000
Project: Identification of novel
immunotherapy targets for AML using computational genomics and mass
spectrometry
|
| 2017-2018 |
George A. Calin, MD, PhD - $25,000
MD Anderson Cancer Center
Project: XenomiRNAs as Biomarkers to Predict CLL Patients Response to
Therapy.
Maro Ohanian, MD - $25,000
MD Anderson Cancer Center
Project: Toxic metals and Acute Myeloid Leukemia in Louisiana
Victoria Belancio, PhD - $25,000
Tulane University School of Medicine
Project: Expression of transposable elements in leukemia patients may
cause genomic instability contributing to the disease.
Rachel E. Rau, MD - $25,000
Baylor College of Medicine
Project: Defining the role of IKZF1 in pediatric ph+B cell ALL |
| 2018-2019 |
Nakhle
Saba, MD - Tulane
- University School of Medicine $30,000
Project: Targeting MALTI
with the small molecule inhibitor MI-2 in B Cell Acute.
Rashmi Kanagal-Shamanna, MD
- MD Anderson Cancer Center $30,000
Project: Altered expression
of H-ferritin can be used as novel biomarker for diagnosis,
sub-classification and monitoring therapy response of patients with
myelodysplastic syndrome associated with SF3B1 mutation.
Katerina Kourentz, PhD
- University of Houston $25,000
Project: Towards rapid
identification of life-threatening acute promyelocytic leukemia.
|
| 2019-2020 |
Firas Safa, MD Grant - $20,000
Tulane University School of Medicine
PROJECT: Establishment and Characterization of a New Mantle Cell
Lymphoma Cell Line, ArBo
Zachary F. Pursell, PhD Grant $30,000
Tulane University School of Medicine
PROJECT: Cooperation of p53 and Pole mutations in hypermutated
lymphomagenesis
Samuel J. Landry, PhD Grant $30,000
Tulane University School of Medicine
PROJECT: Neo-epitopes for tumor vaccines
Grant:
Bing Z. Carter, PhD Grant $30,000
The University of Texas MD Anderson Cancer Center
PROJECT: Inhibition of FAK improves therapeutic efficacy in acute
myeloid leukemia by targeting both leukemia and the leukemia microenvir. |
| 2020-2021 |
Zongbing You, MD, PhD -
$35,000
Tulane University
Project: The role of IL-17 in GSK-3 inhibitor of leukemia
William C. Wimley, PhD - $32,502
Tulane School of Medicine
Project: Evolution of peptide delivery vehicles for therapeutic
antibodies
Qinyan Yin, PhD - $35,000
Tulane University School of Medicine
Project: Development of Arsenic Trioxide as a Potential Therapeutic for
EBV-Associated Lymphomas
Jacob Junco, PhD - $35,000
Baylor College of Medicine
Project: Targeting Chemoresistance using a novel murine Model T-cell
acute lymphoblastic leukemia
Hussein A. Abbas, MD, PhD- $29,256
MD Anderson Cancer Center
Project: Cell by cell Dissection of the Immune Milieu Determinants of
Resistance to Hypomethylating Agents in Older Patients with Acute
Myeloid Leukemia |
| 2022-2023 |
Xiao Ni, MD, PhD
Grant $35,000
The University of Texas
MD Anderson Cancer Center
Project: CCR4 Antagonists in cutaneous T-Cell
Lymphoma (CTCL)
Matthew Burow, PhD
Grant $35,000
Tulane School of Medicine, Dept of Medicine
Project: Utilization of the kinase
chemo-genomic set to identify targets of therapeutic opportunity in MCL
Hua Lu, MD, PhD
Grant $35,000
Tulane University School of Medicine
Project: Developing Nano-encapsulated INZ-C as a
potential and novel leukemia/lymphoma therapeutic agent.
Zhen Lin, MD, PhD
Grant $35,000
Tulane University School of Medicine
Project: Developing a novel targeted
oncolytic therapy for Epstein-Barr virus (EBV) associated lymphoma
|
Ladies Leukemia League, Inc.
P.O. Box 9355
Metairie, LA 70055-9355
I.D.# 72-0997410
|